Tag - Lake Street Capital Markets

Markets

Lake Street analyst pitches Profound Medical as one of his ‘best ideas’ for 2025

Lake Street Capital Markets senior research analyst, Ben Haynor, issued a research note today on Profound Medical (NASDAQ:PROF; TSX:PRN), reiterating his ‘buy’ rating and $17 target price on the company’s stock...

January 2, 2025

Executive Moves

Veteran life science equity analyst Chad Messer joins Lake Street Capital Markets

Seasoned life science equity analyst, Chad Messer, Ph.D., has joined Lake Street Capital Markets as a managing director of equity research. Based in New York, Dr. Messer has over two decades of experience spanning...

January 2, 2025

Markets

Lake Street starts Profound Medical at buy; PT $22 (U.S.)

Lake Street Capital Markets launched coverage of Profound Medical (NASDAQ:PROF; TSX:PRN) with a “buy” rating and $22 (U.S.) price target. The stock closed at $15.11 on Sept. 10. Profound develops, manufactures, and...

September 11, 2020

Tag - Lake Street Capital Markets

Lake Street analyst pitches Profound Medical as one of his ‘best ideas’ for 2025

Veteran life science equity analyst Chad Messer joins Lake Street Capital Markets

Lake Street starts Profound Medical at buy; PT $22 (U.S.)

General

More